Literature DB >> 30965366

[Multimedia E-Learning in Surgery, 10 Years Experience at the University of Würzburg].

Alexander Wierlemann1, Florian Seyfried1, Christoph Thomas Germer1.   

Abstract

BACKGROUND: Digital content on the internet has become an important learning resource for medical students. E-learning can play a major part in supporting learning processes. At the same time, educational content on the internet can reach a greater audience than traditional learning formats.
METHODS: In addition to the curricular learning program of the surgical university hospital Würzburg, an open-access e-learning platform was established which covers the complete topic of general and visceral surgery, presented with multimedia and interactive elements.
RESULTS: In the period from February 2010 to April 2018, 1,444,806 pageviews where counted on the different websites of e-learning. 350,212 users accessed the platform, 24.04% from mobile devices or tablets.
CONCLUSION: With open source software it is possible to establish a modern e-learning resource. In order to maximise the reach of the e-learning beyond the own faculty, it is crucial not to use proprietary standards, but to respect a platform-independent technical design and to make the content strictly public accessible. In future development, greater emphasis should be put on personalising the e-learning experience in order to better understand the effects on the learning results. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 30965366     DOI: 10.1055/a-0833-8892

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  Surviving the COVID - 19 Pandemic Resurgence: Not Easy but Achievable.

Authors:  Iakovos N Nomikos
Journal:  Hell Cheirourgike       Date:  2021-03-22

Review 2.  [The role of postdoctoral qualification candidates in surgical teaching].

Authors:  Christoph Paasch; Carl Meißner; Frank Meyer
Journal:  Chirurg       Date:  2021-04-14       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.